Skip to content

VIESVILLE PHARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

VIESVILLE PHARMA

BE 0444.043.927
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€51,339
2024 · €54,054-€2,715
Equity
€393,723
2024 · €342,384+€51,339
Cash
€193,375
2024 · €197,944-€4,569
Balance sheet total
€470,253
2024 · €460,341+€9,912

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€23,383

    up €23,383 (+30.5%), from €76,640 to €100,023

    of which Trade receivables: +€18,454

  • Stocks and contracts -€10,772

    down €10,772 (-12.2%), from €87,965 to €77,193

Equity and liabilities
  • Reserves +€51,339

    up €51,339 (+15.3%), from €336,179 to €387,518

    of which Distributable reserves: +€51,339

  • Trade debts -€49,485

    down €49,485 (-65.6%), from €75,440 to €25,956

  • Other debts +€14,239

    up €14,239 (+193%), from €7,360 to €21,599

  • Current portion of long-term debt -€6,138

    no longer reported in 2025 (was €6,138)

Income statement
  • Gross operating margin -€11,533

    down €11,533 (-7.8%), from €148,151 to €136,618

  • Staff costs -€6,607

    down €6,607 (-10.8%), from €60,915 to €54,308

  • Taxes -€1,578

    down €1,578 (-10.2%), from €15,530 to €13,952

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €54,054
Gross operating margin -€11,533
Staff costs +€6,607
Depreciation +€31
Other operating charges +€79
Financial income +€188
Financial charges +€336
Taxes +€1,578
Result 2025 €51,339
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€16,981
Investment -€15,411
Financing -€6,138
Cash 2024 €197,944
Net result for the year +€51,339
Depreciation +€13,337
Stocks and contracts +€10,772
Receivables within one year -€23,383
Deferred charges and accrued income +€204
Trade debts -€49,485
Tax, wage and social debts -€165
Other debts +€14,239
Accrued charges and deferred income +€122
Investment in fixed assets (net) -€14,906
Current investments -€505
Current portion of long-term debt -€6,138
Cash 2025 €193,375
brings cash intakes cash out
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €460,341 €470,253 +€9,912 +2.2%
Fixed assets 21/28 €80,232 €81,801 +€1,569 +2.0%
Tangible fixed assets 22/27 €80,232 €81,801 +€1,569 +2.0%
Land and buildings 22 €77,675 €69,446 -€8,229 -10.6%
Plant, machinery and equipment 23 €1,812 €1,421 -€391 -21.6%
Furniture and vehicles 24 €745 €10,933 +€10,188 +1,368%
Current assets 29/58 €380,109 €388,452 +€8,343 +2.2%
Stocks and contracts in progress 3 €87,965 €77,193 -€10,772 -12.2%
Stocks 30/36 €87,965 €77,193 -€10,772 -12.2%
Amounts receivable within one year 40/41 €76,640 €100,023 +€23,383 +30.5%
Trade receivables 40 €51,920 €70,374 +€18,454 +35.5%
Other amounts receivable 41 €24,721 €29,649 +€4,928 +19.9%
Current investments 50/53 €16,823 €17,328 +€505 +3.0%
Cash at bank and in hand 54/58 €197,944 €193,375 -€4,569 -2.3%
Deferred charges and accrued income 490/1 €737 €533 -€204 -27.7%
Total equity and liabilities 10/49 €460,341 €470,253 +€9,912 +2.2%
Equity 10/15 €342,384 €393,723 +€51,339 +15.0%
Contributions 10/11 €6,205 €6,205 = 0.0%
Reserves 13 €336,179 €387,518 +€51,339 +15.3%
Non-distributable reserves 130/1 €1,859 €1,859 = 0.0%
Reserves not available under the articles 1311 €1,859 €1,859 = 0.0%
Tax-exempt reserves 132 €15,276 €15,276 = 0.0%
Distributable reserves 133 €319,043 €370,382 +€51,339 +16.1%
Provisions and deferred taxes 16 €647 €647 = 0.0%
Provisions for liabilities and charges 160/5 €647 €647 = 0.0%
Environmental obligations 163 €647 €647 = 0.0%
Amounts payable 17/49 €117,310 €75,883 -€41,427 -35.3%
Amounts payable within one year 42/48 €109,148 €67,598 -€41,549 -38.1%
Current portion of amounts payable after more than one year 42 €6,138 - -€6,138
Trade debts 44 €75,440 €25,956 -€49,485 -65.6%
Suppliers 440/4 €75,440 €25,956 -€49,485 -65.6%
Taxes, remuneration and social security 45 €20,209 €20,044 -€165 -0.8%
Taxes 450/3 €11,569 €9,101 -€2,468 -21.3%
Remuneration and social security 454/9 €8,640 €10,943 +€2,303 +26.7%
Other amounts payable 47/48 €7,360 €21,599 +€14,239 +193%
Accrued charges and deferred income 492/3 €8,162 €8,284 +€122 +1.5%
Remuneration, social security and pensions 62 €60,915 €54,308 -€6,607 -10.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €13,368 €13,337 -€31 -0.2%
Other operating charges 640/8 €3,308 €3,229 -€79 -2.4%
Gross operating margin 9900 €148,151 €136,618 -€11,533 -7.8%
Operating profit (loss) 9901 €70,560 €65,744 -€4,816 -6.8%
Financial income 75/76B €1,169 €1,357 +€188 +16.1%
Recurring financial income 75 €1,169 €1,357 +€188 +16.1%
Financial charges 65/66B €2,145 €1,809 -€336 -15.7%
Recurring financial charges 65 €2,145 €1,809 -€336 -15.7%
Profit (loss) for the period before taxes 9903 €69,584 €65,291 -€4,293 -6.2%
Income taxes 67/77 €15,530 €13,952 -€1,578 -10.2%
Profit (loss) for the period 9904 €54,054 €51,339 -€2,715 -5.0%
Profit (loss) for the period to be appropriated 9905 €54,054 €51,339 -€2,715 -5.0%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.